Literature DB >> 16854842

Evaluation of multiprotein immunoaffinity subtraction for plasma proteomics and candidate biomarker discovery using mass spectrometry.

Tao Liu1, Wei-Jun Qian, Heather M Mottaz, Marina A Gritsenko, Angela D Norbeck, Ronald J Moore, Samuel O Purvine, David G Camp, Richard D Smith.   

Abstract

Strategies for removal of high abundance proteins have been increasingly utilized in proteomic studies of serum/plasma and other body fluids to enhance the detection of low abundance proteins and achieve broader proteome coverage; however, both the reproducibility and specificity of the high abundance protein depletion process still represent common concerns. Here we report a detailed evaluation of immunoaffinity subtraction performed applying the ProteomeLab IgY-12 system that is commonly used in human serum/plasma proteome characterization in combination with high resolution LC-MS/MS. Plasma samples were repeatedly processed using this approach, and the resulting flow-through fractions and bound fractions were individually analyzed for comparison. The removal of target proteins by the immunoaffinity subtraction system and the overall process was highly reproducible. Non-target proteins, including one spiked protein standard (rabbit glyceraldehyde-3-phosphate dehydrogenase), were also observed to bind to the column at different levels but also in a reproducible manner. The results suggest that multiprotein immunoaffinity subtraction systems can be readily integrated into quantitative strategies to enhance detection of low abundance proteins in biomarker discovery studies.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854842      PMCID: PMC1850944          DOI: 10.1074/mcp.T600039-MCP200

Source DB:  PubMed          Journal:  Mol Cell Proteomics        ISSN: 1535-9476            Impact factor:   5.911


  21 in total

1.  Packed capillary reversed-phase liquid chromatography with high-performance electrospray ionization Fourier transform ion cyclotron resonance mass spectrometry for proteomics.

Authors:  Y Shen; R Zhao; M E Belov; T P Conrads; G A Anderson; K Tang; L Pasa-Tolić; T D Veenstra; M S Lipton; H R Udseth; R D Smith
Journal:  Anal Chem       Date:  2001-04-15       Impact factor: 6.986

2.  Multi-component immunoaffinity subtraction chromatography: an innovative step towards a comprehensive survey of the human plasma proteome.

Authors:  Rembert Pieper; Qin Su; Christine L Gatlin; Shih-Ting Huang; N Leigh Anderson; Sandra Steiner
Journal:  Proteomics       Date:  2003-04       Impact factor: 3.984

Review 3.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

4.  A statistical model for identifying proteins by tandem mass spectrometry.

Authors:  Alexey I Nesvizhskii; Andrew Keller; Eugene Kolker; Ruedi Aebersold
Journal:  Anal Chem       Date:  2003-09-01       Impact factor: 6.986

5.  Characterization of the low molecular weight human serum proteome.

Authors:  Radhakrishna S Tirumalai; King C Chan; DaRue A Prieto; Haleem J Issaq; Thomas P Conrads; Timothy D Veenstra
Journal:  Mol Cell Proteomics       Date:  2003-08-13       Impact factor: 5.911

6.  An investigation into the human serum "interactome".

Authors:  Ming Zhou; David A Lucas; King C Chan; Haleem J Issaq; Emanuel F Petricoin; Lance A Liotta; Timothy D Veenstra; Thomas P Conrads
Journal:  Electrophoresis       Date:  2004-05       Impact factor: 3.535

7.  A model for random sampling and estimation of relative protein abundance in shotgun proteomics.

Authors:  Hongbin Liu; Rovshan G Sadygov; John R Yates
Journal:  Anal Chem       Date:  2004-07-15       Impact factor: 6.986

8.  Proteomic analysis of human serum by two-dimensional differential gel electrophoresis after depletion of high-abundant proteins.

Authors:  Brett A Chromy; Arlene D Gonzales; Julie Perkins; Megan W Choi; Michele H Corzett; Brian C Chang; Christopher H Corzett; Sandra L McCutchen-Maloney
Journal:  J Proteome Res       Date:  2004 Nov-Dec       Impact factor: 4.466

9.  Hydrophobic ligand binding by Zn-alpha 2-glycoprotein, a soluble fat-depleting factor related to major histocompatibility complex proteins.

Authors:  M W Kennedy; A P Heikema; A Cooper; P J Bjorkman; L M Sanchez
Journal:  J Biol Chem       Date:  2001-06-25       Impact factor: 5.157

10.  Zinc-alpha2-glycoprotein, a lipid mobilizing factor, is expressed in adipocytes and is up-regulated in mice with cancer cachexia.

Authors:  Chen Bing; Yi Bao; John Jenkins; Paul Sanders; Monia Manieri; Saverio Cinti; Michael J Tisdale; Paul Trayhurn
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  80 in total

1.  Depletion of hemoglobin and carbonic anhydrase from erythrocyte cytosolic samples by preparative clear native electrophoresis.

Authors:  Gian Maria D'Amici; Sara Rinalducci; Lello Zolla
Journal:  Nat Protoc       Date:  2011-12-08       Impact factor: 13.491

2.  Combining ultracentrifugation and peptide termini group-specific immunoprecipitation for multiplex plasma protein analysis.

Authors:  Sonja Volk; Thomas D Schreiber; David Eisen; Calvin Wiese; Hannes Planatscher; Christopher J Pynn; Dieter Stoll; Markus F Templin; Thomas O Joos; Oliver Pötz
Journal:  Mol Cell Proteomics       Date:  2012-04-23       Impact factor: 5.911

3.  Proteomic technologies for the discovery of type 1 diabetes biomarkers.

Authors:  Wenbo Zhi; Sharad Purohit; Colleen Carey; Meiyao Wang; Jin-Xiong She
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

4.  Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury.

Authors:  Hasmik Keshishian; Michael W Burgess; Michael A Gillette; Philipp Mertins; Karl R Clauser; D R Mani; Eric W Kuhn; Laurie A Farrell; Robert E Gerszten; Steven A Carr
Journal:  Mol Cell Proteomics       Date:  2015-02-27       Impact factor: 5.911

5.  Enrichment of high affinity subclasses and glycoforms from serum-derived IgG using FcγRs as affinity ligands.

Authors:  Austin W Boesch; James H Kappel; Alison E Mahan; Thach H Chu; Andrew R Crowley; Nana Y Osei-Owusu; Galit Alter; Margaret E Ackerman
Journal:  Biotechnol Bioeng       Date:  2018-02-01       Impact factor: 4.530

Review 6.  Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications.

Authors:  Wei-Jun Qian; Jon M Jacobs; Tao Liu; David G Camp; Richard D Smith
Journal:  Mol Cell Proteomics       Date:  2006-08-03       Impact factor: 5.911

7.  Evaluating the effects of preanalytical variables on the stability of the human plasma proteome.

Authors:  Maria E Hassis; Richard K Niles; Miles N Braten; Matthew E Albertolle; H Ewa Witkowska; Carl A Hubel; Susan J Fisher; Katherine E Williams
Journal:  Anal Biochem       Date:  2015-03-10       Impact factor: 3.365

8.  Assessment of albumin removal from an immunoaffinity spin column: critical implications for proteomic examination of the albuminome and albumin-depleted samples.

Authors:  Rebekah L Gundry; Melanie Y White; Julie Nogee; Irina Tchernyshyov; Jennifer E Van Eyk
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

9.  Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.

Authors:  Lang-Ming Chi; Chien-Wei Lee; Kai-Ping Chang; Sheng-Po Hao; Hang-Mao Lee; Ying Liang; Chuen Hsueh; Chia-Jung Yu; I-Neng Lee; Yin-Ju Chang; Shih-Ying Lee; Yuan-Ming Yeh; Yu-Sun Chang; Kun-Yi Chien; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

10.  Analysis of serum total and free PSA using immunoaffinity depletion coupled to SRM: correlation with clinical immunoassay tests.

Authors:  Tao Liu; Mahmud Hossain; Athena A Schepmoes; Thomas L Fillmore; Lori J Sokoll; Scott R Kronewitter; Grant Izmirlian; Tujin Shi; Wei-Jun Qian; Robin J Leach; Ian M Thompson; Daniel W Chan; Richard D Smith; Jacob Kagan; Sudhir Srivastava; Karin D Rodland; David G Camp
Journal:  J Proteomics       Date:  2012-02-13       Impact factor: 4.044

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.